Acceleron Pharma Inc (NASDAQ:XLRN)

106.49
Delayed Data
As of Sep 18
 +2.26 / +2.17%
Today’s Change
37.60
Today|||52-Week Range
110.75
+100.85%
Year-to-Date
Acceleron Looks To Next Therapy After Reblozyl Launch
Aug 26 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close104.23
Today’s open104.76
Day’s range102.91 - 106.67
Volume11,257
Average volume (3 months)642,827
Market cap$6.4B
Data as of 3:59pm ET, 09/18/2020

Growth & Valuation

Earnings growth (last year)+8.09%
Earnings growth (this year)-3.29%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+428.86%
P/E ratioNM
Price/Sales37.59
Price/Book12.59

Competitors

 Today’s
change
Today’s
% change
MNTAMomenta Pharmaceutic...-0.03-0.06%
NVAXNovavax Inc-7.11-6.16%
CRSPCRISPR Therapeutics ...+0.76+0.89%
ZLABZai Lab Ltd-1.59-1.97%
Data as of 4:20pm ET, 09/18/2020

Financials

Next reporting dateNovember 4, 2020
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$74.0M
Annual profit (last year)-$124.9M
Net profit margin-168.74%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts